Show simple item record

Proteomic approaches to improve cancer therapy – Identifying factors contributing to melphalan resistance in multiple myeloma and to PDT mediated cytotoxicity

dc.contributor.authorZub, Kamila Annanb_NO
dc.date.accessioned2014-12-19T14:19:05Z
dc.date.available2014-12-19T14:19:05Z
dc.date.created2014-07-03nb_NO
dc.date.issued2014nb_NO
dc.identifier732201nb_NO
dc.identifier.isbn978-82-326-0216-2 (printed ver.)nb_NO
dc.identifier.isbn978-82-326-0217-9 (electronic ver.)nb_NO
dc.identifier.urihttp://hdl.handle.net/11250/263696
dc.languageengnb_NO
dc.publisherNorges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for kreftforskning og molekylær medisinnb_NO
dc.relation.ispartofseriesDoktoravhandlinger ved NTNU, 1503-8181; 2014:147nb_NO
dc.titleProteomic approaches to improve cancer therapy – Identifying factors contributing to melphalan resistance in multiple myeloma and to PDT mediated cytotoxicitynb_NO
dc.typeDoctoral thesisnb_NO
dc.contributor.departmentNorges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for kreftforskning og molekylær medisinnb_NO
dc.description.degreePhD i molekylærmedisinnb_NO
dc.description.degreePhD in Molecular Medicineen_GB


Files in this item

Thumbnail
Name:
732201_FULLTEXT01.pdf
Size:
15.01Mb
Format:
PDF
Locked

This item appears in the following Collection(s)

Show simple item record